Molecular and biological changes associated with HeLa cell attenuation of wild-type yellow fever virus

Lee M. Dunster, Heiman Wang, Kate D. Ryman, Barry R. Miller, Stanley Watowich, Philip D. Minor, Alan Barrett

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Six passages of the mosquito-borne flavivirus yellow fever (YF) wild- type strain Asibi in HeLa cells attenuated the virus for monkeys and newborn mice and resulted in loss of mosquito competence. Attenuation after the passage in HeLa cells was not unique to YF virus strain Asibi as demonstrated by the HeLa passage attenuation of wild-type YF virus strain French viscerotropic virus and YF vaccine virus 17D-204 for newborn mice. In contrast, wild-type strain Dakar 1279 and the French neurotropic vaccine virus remained virulent for newborn mice after six passages in HeLa cells. Thus not all strains of YF virus can be attenuated by passage in HeLa cells. Attenuation of YF virus strains Asibi and French viscerotropic virus was accompanied by alterations in the antigenic and biological properties of the viruses, including changes to envelope protein epitopes. Attenuation for newborn mice was coincidental with the acquisition by the HeLa-passaged viruses of the vaccine-specific envelope protein epitope recognized by monoclonal antibody H5. This suggests that this conformational change may play a role in the attenuation process. Wild-type Dakar 1279, which remained virulent for newborn mice after passage in HeLa cells, retained its wild-type antigenic character. The genome of Asibi p6 virus differed from wild-type Asibi virus by 29 nucleotides that encoded 10 amino acid substitutions: 5 in the envelope protein, I in NS2A, 3 in NS4B, and 1 in NS5. The substitution at NS4B-95 is seen in three different attenuation processes of wild-type YF virus, leading us to speculate that it is involved in the attenuation of virulence of wild type strain Asibi.

Original languageEnglish (US)
Pages (from-to)309-318
Number of pages10
JournalVirology
Volume261
Issue number2
DOIs
StatePublished - Sep 1 1999

Fingerprint

Yellow fever virus
HeLa Cells
Viruses
Culicidae
Epitopes
Vaccines
Yellow Fever Vaccine
Yellow Fever
Flavivirus
Proteins
Amino Acid Substitution
Mental Competency
Haplorhini
Virulence
Nucleotides
Monoclonal Antibodies
Genome

Keywords

  • Attenuation
  • Flavivirus
  • Yellow fever virus

ASJC Scopus subject areas

  • Virology
  • Infectious Diseases

Cite this

Molecular and biological changes associated with HeLa cell attenuation of wild-type yellow fever virus. / Dunster, Lee M.; Wang, Heiman; Ryman, Kate D.; Miller, Barry R.; Watowich, Stanley; Minor, Philip D.; Barrett, Alan.

In: Virology, Vol. 261, No. 2, 01.09.1999, p. 309-318.

Research output: Contribution to journalArticle

Dunster, Lee M. ; Wang, Heiman ; Ryman, Kate D. ; Miller, Barry R. ; Watowich, Stanley ; Minor, Philip D. ; Barrett, Alan. / Molecular and biological changes associated with HeLa cell attenuation of wild-type yellow fever virus. In: Virology. 1999 ; Vol. 261, No. 2. pp. 309-318.
@article{a1ba23dc7289442f9bbfe0c0f96b1dbb,
title = "Molecular and biological changes associated with HeLa cell attenuation of wild-type yellow fever virus",
abstract = "Six passages of the mosquito-borne flavivirus yellow fever (YF) wild- type strain Asibi in HeLa cells attenuated the virus for monkeys and newborn mice and resulted in loss of mosquito competence. Attenuation after the passage in HeLa cells was not unique to YF virus strain Asibi as demonstrated by the HeLa passage attenuation of wild-type YF virus strain French viscerotropic virus and YF vaccine virus 17D-204 for newborn mice. In contrast, wild-type strain Dakar 1279 and the French neurotropic vaccine virus remained virulent for newborn mice after six passages in HeLa cells. Thus not all strains of YF virus can be attenuated by passage in HeLa cells. Attenuation of YF virus strains Asibi and French viscerotropic virus was accompanied by alterations in the antigenic and biological properties of the viruses, including changes to envelope protein epitopes. Attenuation for newborn mice was coincidental with the acquisition by the HeLa-passaged viruses of the vaccine-specific envelope protein epitope recognized by monoclonal antibody H5. This suggests that this conformational change may play a role in the attenuation process. Wild-type Dakar 1279, which remained virulent for newborn mice after passage in HeLa cells, retained its wild-type antigenic character. The genome of Asibi p6 virus differed from wild-type Asibi virus by 29 nucleotides that encoded 10 amino acid substitutions: 5 in the envelope protein, I in NS2A, 3 in NS4B, and 1 in NS5. The substitution at NS4B-95 is seen in three different attenuation processes of wild-type YF virus, leading us to speculate that it is involved in the attenuation of virulence of wild type strain Asibi.",
keywords = "Attenuation, Flavivirus, Yellow fever virus",
author = "Dunster, {Lee M.} and Heiman Wang and Ryman, {Kate D.} and Miller, {Barry R.} and Stanley Watowich and Minor, {Philip D.} and Alan Barrett",
year = "1999",
month = "9",
day = "1",
doi = "10.1006/viro.1999.9873",
language = "English (US)",
volume = "261",
pages = "309--318",
journal = "Virology",
issn = "0042-6822",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Molecular and biological changes associated with HeLa cell attenuation of wild-type yellow fever virus

AU - Dunster, Lee M.

AU - Wang, Heiman

AU - Ryman, Kate D.

AU - Miller, Barry R.

AU - Watowich, Stanley

AU - Minor, Philip D.

AU - Barrett, Alan

PY - 1999/9/1

Y1 - 1999/9/1

N2 - Six passages of the mosquito-borne flavivirus yellow fever (YF) wild- type strain Asibi in HeLa cells attenuated the virus for monkeys and newborn mice and resulted in loss of mosquito competence. Attenuation after the passage in HeLa cells was not unique to YF virus strain Asibi as demonstrated by the HeLa passage attenuation of wild-type YF virus strain French viscerotropic virus and YF vaccine virus 17D-204 for newborn mice. In contrast, wild-type strain Dakar 1279 and the French neurotropic vaccine virus remained virulent for newborn mice after six passages in HeLa cells. Thus not all strains of YF virus can be attenuated by passage in HeLa cells. Attenuation of YF virus strains Asibi and French viscerotropic virus was accompanied by alterations in the antigenic and biological properties of the viruses, including changes to envelope protein epitopes. Attenuation for newborn mice was coincidental with the acquisition by the HeLa-passaged viruses of the vaccine-specific envelope protein epitope recognized by monoclonal antibody H5. This suggests that this conformational change may play a role in the attenuation process. Wild-type Dakar 1279, which remained virulent for newborn mice after passage in HeLa cells, retained its wild-type antigenic character. The genome of Asibi p6 virus differed from wild-type Asibi virus by 29 nucleotides that encoded 10 amino acid substitutions: 5 in the envelope protein, I in NS2A, 3 in NS4B, and 1 in NS5. The substitution at NS4B-95 is seen in three different attenuation processes of wild-type YF virus, leading us to speculate that it is involved in the attenuation of virulence of wild type strain Asibi.

AB - Six passages of the mosquito-borne flavivirus yellow fever (YF) wild- type strain Asibi in HeLa cells attenuated the virus for monkeys and newborn mice and resulted in loss of mosquito competence. Attenuation after the passage in HeLa cells was not unique to YF virus strain Asibi as demonstrated by the HeLa passage attenuation of wild-type YF virus strain French viscerotropic virus and YF vaccine virus 17D-204 for newborn mice. In contrast, wild-type strain Dakar 1279 and the French neurotropic vaccine virus remained virulent for newborn mice after six passages in HeLa cells. Thus not all strains of YF virus can be attenuated by passage in HeLa cells. Attenuation of YF virus strains Asibi and French viscerotropic virus was accompanied by alterations in the antigenic and biological properties of the viruses, including changes to envelope protein epitopes. Attenuation for newborn mice was coincidental with the acquisition by the HeLa-passaged viruses of the vaccine-specific envelope protein epitope recognized by monoclonal antibody H5. This suggests that this conformational change may play a role in the attenuation process. Wild-type Dakar 1279, which remained virulent for newborn mice after passage in HeLa cells, retained its wild-type antigenic character. The genome of Asibi p6 virus differed from wild-type Asibi virus by 29 nucleotides that encoded 10 amino acid substitutions: 5 in the envelope protein, I in NS2A, 3 in NS4B, and 1 in NS5. The substitution at NS4B-95 is seen in three different attenuation processes of wild-type YF virus, leading us to speculate that it is involved in the attenuation of virulence of wild type strain Asibi.

KW - Attenuation

KW - Flavivirus

KW - Yellow fever virus

UR - http://www.scopus.com/inward/record.url?scp=0033199105&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033199105&partnerID=8YFLogxK

U2 - 10.1006/viro.1999.9873

DO - 10.1006/viro.1999.9873

M3 - Article

C2 - 10497116

AN - SCOPUS:0033199105

VL - 261

SP - 309

EP - 318

JO - Virology

JF - Virology

SN - 0042-6822

IS - 2

ER -